X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (16) 16
index medicus (14) 14
humans (11) 11
female (9) 9
analysis (6) 6
cancer (6) 6
middle aged (6) 6
adult (5) 5
aged (5) 5
breast cancer (5) 5
melanoma (5) 5
metastasis (5) 5
patients (5) 5
surgery (5) 5
abridged index medicus (4) 4
aged, 80 and over (4) 4
breast neoplasms - metabolism (4) 4
chemotherapy (4) 4
male (4) 4
metastases (4) 4
neoplasm staging (4) 4
pembrolizumab (4) 4
survival (4) 4
antineoplastic agents - therapeutic use (3) 3
drug therapy (3) 3
estrogen-receptor (3) 3
immune checkpoint (3) 3
immunotherapy (3) 3
ipilimumab (3) 3
lymph nodes (3) 3
lymphatic system (3) 3
pd-1 protein (3) 3
prognosis (3) 3
radiation (3) 3
radiotherapy (3) 3
risk groups (3) 3
studies (3) 3
treatment outcome (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
article (2) 2
breast neoplasms - drug therapy (2) 2
breast neoplasms - pathology (2) 2
breast neoplasms - surgery (2) 2
cancer therapies (2) 2
care and treatment (2) 2
clinical trials (2) 2
confidence intervals (2) 2
disease-free survival (2) 2
eortc 18952 (2) 2
genetic aspects (2) 2
hospitals (2) 2
mastectomy (2) 2
medicine, general & internal (2) 2
mutation (2) 2
node-positive melanoma (2) 2
patient outcomes (2) 2
patterns (2) 2
pegylated interferon-alpha-2b (2) 2
postmenopausal women (2) 2
radiation therapy (2) 2
randomized controlled trials as topic (2) 2
receptor, erbb-2 - metabolism (2) 2
retrospective studies (2) 2
risk (2) 2
skin neoplasms - drug therapy (2) 2
squamous cell carcinoma (2) 2
statistical analysis (2) 2
survival rate (2) 2
therapy (2) 2
tumor burden (2) 2
tumors (2) 2
20-year follow-up (1) 1
4/6 inhibitor palbociclib (1) 1
abemaciclib (1) 1
acetylcysteine (1) 1
activation (1) 1
adaptor proteins, signal transducing - metabolism (1) 1
adjuvant (1) 1
adjuvant chemotherapy (1) 1
adjuvant endocrine (1) 1
adjuvant endocrine therapy (1) 1
adjuvant her-2-targeted therapy (1) 1
adjuvant therapy (1) 1
adjuvant treatment (1) 1
adjuvant treatment of cancer (1) 1
adjuvants, immunologic - adverse effects (1) 1
adjuvants, immunologic - therapeutic use (1) 1
ajcc-7 (1) 1
ajcc-8 (1) 1
alanine (1) 1
alanine transaminase (1) 1
american joint committee (1) 1
american-society (1) 1
amplification (1) 1
androgen antagonists - therapeutic use (1) 1
animals (1) 1
anthracycline (1) 1
anthracyclines (1) 1
anthracyclines - administration & dosage (1) 1
anti-bacterial agents - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 19, pp. 1789 - 1801
A blinded trial involving patients with resected stage III melanoma showed that adjuvant pembrolizumab every 3 weeks for a year was associated with a 1-year... 
HIGH-RISK MELANOMA | SURVIVAL | MEDICINE, GENERAL & INTERNAL | ANTI-PD-1 THERAPY | EORTC 18952 | TUMOR BURDEN | CUTANEOUS MELANOMA | PHASE-3 TRIAL | PEGYLATED INTERFERON-ALPHA-2B | NODE-POSITIVE MELANOMA | IPILIMUMAB | Skin Neoplasms - drug therapy | Humans | Middle Aged | Male | Adjuvants, Immunologic - adverse effects | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Adjuvants, Immunologic - therapeutic use | Skin Neoplasms - surgery | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Survival Rate | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Melanoma - drug therapy | Intention to Treat Analysis | Quality of Life | Aged | B7-H1 Antigen - analysis | Infusions, Intravenous | Melanoma - surgery | Neoplasm Staging | Melanoma - mortality | Diagnosis | Drug therapy | Patients | Health aspects | Melanoma | Medical research | Lymphatic system | Risk groups | PD-1 protein | Committees | Metastasis | Survival | Skin cancer | Pembrolizumab | Hospitals | Motivation | PD-L1 protein | Myositis | Death | Mutation | Tumors | Cancer | Index Medicus | Abridged Index Medicus | Placebos | Placebos (Medicine) | Adjuvant treatment of cancer | Tractament adjuvant del càncer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 4, pp. 341 - 351
Journal Article
by Maio, Michele and Lewis, Karl and Demidov, Lev and Mandalà, Mario and Bondarenko, Igor and Ascierto, Paolo A and Herbert, Christopher and Mackiewicz, Andrzej and Rutkowski, Piotr and Guminski, Alexander and Goodman, Grant R and Simmons, Brian and Ye, Chenglin and Yan, Yibing and Schadendorf, Dirk and Cinat, Gabriela and Fein, Luis Enrique and Brown, Michael and Guminski, Alexander and Haydon, Andrew and Khattak, Adnan and McNeil, Catriona and Parente, Phillip and Power, Jeremy and Roberts-Thomson, Rachel and Sandhu, Shahneen and Underhill, Craig and Varma, Suresh and Berger, Thomas and Awada, Ahmad and Blockx, Nathalie and Buyse, Veronique and Mebis, Jeroen and Franke, Fábio André and Jobim de Azevedo, Sérgio and Silva Lazaretti, Nicolas and Jamal, Rahima and Mihalcioiu, Catalin and Petrella, Teresa and Savage, Kerry and Song, Xinni and Wong, Ralph and Dabelic, Nina and Plestina, Stjepko and Vojnovic, Zeljko and Arenberger, Petr and Kocak, Ivo and Krajsova, Ivana and Kubala, Eugen and Melichar, Bohuslav and Vantuchova, Yvetta and Putnik, Kadri and Dreno, Brigitte and Dutriaux, Caroline and Grob, Jean-Jacques and Joly, Pascal and Lacour, Jean-Philippe and Meyer, Nicolas and Mortier, Laurent and Thomas, Luc and Fluck, Michael and Gambichler, Thilo and Hassel, Jessica and Hauschild, Axel and Schadendorf, Dirk and Donnellan, Paul and McCaffrey, John and Power, Derek and Ariad, Samuel and Bar-Sela, Gil and Hendler, Daniel and Ron, Ilan and Schachter, Jacob and Ascierto, Paolo and Berruti, Alfredo and Bianchi, Luca and Chiarion Sileni, Vanna and Cognetti, Francesco and Danielli, Riccardo and Di Giacomo, Anna Maria and Gianni, Luca and Goldhirsch, Aron and Guida, Michele and Maio, Michele and Mandalà, Mario and Marchetti, Paolo and Queirolo, Paola and Santoro, Armando and Kapiteijn, Ellen and Mackiewicz, Andrzej and Rutkowski, Piotr and Ferreira, Paula and Demidov, Lev and Gafton, Georgy and Makarova, Yulia and Andric, Zoran and Babovic, Nada and Jovanovic, Darjana and Kandolf Sekulovic, Lidija and Cohen, Graham and ... and BRIM8 Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 510 - 520
Background: Systemic adjuvant treatment might mitigate the high risk of disease recurrence in patients with resected stage IIC–III melanoma. The BRIM8 study... 
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 9592 - 9592
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 3893 - 3893
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 4454 - 4454
Journal Article